Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 20.16M P/E - EPS this Y 59.60% Ern Qtrly Grth -
Income -8.11M Forward P/E -2.49 EPS next Y -2.50% 50D Avg Chg -3.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -23.00%
Dividend N/A Price/Book 5.57 EPS next 5Y - 52W High Chg -65.00%
Recommedations 2.00 Quick Ratio 8.96 Shares Outstanding 23.99M 52W Low Chg 33.00%
Insider Own 1.90% ROA -70.08% Shares Float 23.53M Beta 0.98
Inst Own 3.73% ROE -155.12% Shares Shorted/Prior 51.47K/61.15K Price 1.99
Gross Margin - Profit Margin - Avg. Volume 607,008 Target Price 5.69
Oper. Margin - Earnings Date Aug 13 Volume 12,560 Change -1.00%
About RenovoRx, Inc.

RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing proprietary targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is RenovoGem, an oncology drug-device combination product, consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. The company has a research collaboration with Imugene Limited to deliver oncolytic virus therapy for the treatment of difficult-to-access tumors. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California.

RenovoRx, Inc. News
11/20/24 Northwell Health Cancer Institute Launches Patient Enrollment in RenovoRx’s Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial
11/14/24 RenovoRx Reports Third Quarter 2024 Financial Results and Operational Highlights
09/26/24 We Think RenovoRx (NASDAQ:RNXT) Needs To Drive Business Growth Carefully
09/25/24 RenovoRx Increases Production of FDA-Cleared RenovoCath® Delivery System in Response to Strong Demand from Oncology and Interventional Radiology Physicians
09/19/24 RenovoRx Announces Presentation at Symposium on Clinical Interventional Oncology Highlighting TAMP™ for Targeted Treatment of Locally Advanced Pancreatic Cancer
08/27/24 RenovoRx CEO Shaun Bagai to Present at H.C. Wainwright’s 26th Annual Global Investment Conference on September 9, 2024 in New York
08/14/24 RenovoRx continues drug-device combo Phase III trial in pancreatic cancer
08/14/24 RenovoRx Announces First Patient Enrolled at University of Nebraska Medical Center for the Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial
07/31/24 RenovoRx Announces Publication of Positive Early-Stage Clinical Data in International Peer-Reviewed Journal, The Oncologist®
07/08/24 RenovoRx Announces Acceptance for Publication in the International Peer-Reviewed Journal, The Oncologist®
06/26/24 University of Nebraska Medical Center Launches Patient Enrollment for RenovoRx’s Pivotal Phase III TIGeR-PaC Clinical Trial
05/30/24 RenovoRx CEO Issues Update Letter to Shareholders
05/21/24 Publication of Results of Pre-Clinical Studies Support Efficacy and Drug Delivery Mechanism Potential of RenovoRx’s TAMP™ Therapy Platform to Improve Targeted Cancer Drug Treatment Delivery
05/14/24 RenovoRx to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase on May 21, 2024
05/02/24 RenovoRx CEO Shaun R. Bagai to Present at the Aegis Capital Virtual Conference on May 9, 2024
04/18/24 RenovoRx Regains Compliance with Nasdaq Stockholders’ Equity Requirement
04/16/24 RenovoRx Highlights Recent Presentation of Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting
04/15/24 RenovoRx Closes $11.1 Million Private Placement, Providing Cash Runway into 2026
04/08/24 RenovoRx Announces $11.1 Million at Market Private Placement
04/05/24 RenovoRx to Present at the Canaccord Genuity Horizons in Oncology Virtual Conference on April 15, 2024
RNXT Chatroom

User Image johnnyutah007 Posted - 16 hours ago

$RNXT looking 💪

User Image johnnyutah007 Posted - 1 day ago

$RNXT 👀

User Image enzomassimi Posted - 1 day ago

$RNXT up

User Image enzomassimi Posted - 1 day ago

$RNXT

User Image MadMaverick Posted - 1 day ago

$RNXT $SLXN $TNXP Reversal Baby! just wait until the FOMO kicks in over $1.20 then $1.75 💰 If you're not first, you're last... 🫠

User Image Lucky72 Posted - 1 day ago

$RNXT Good news

User Image BigQuench Posted - 1 day ago

$RNXT BREAKING OUT! Over $1.20 > $1.75+ / Quick Mover 📈 Just announced big news for phase III in conjunction with NHCI. $SUNE $DJT $SMCI Also on breakout watch 👀 Communicated - Disclaimer NFA https://chartingdaily.com/delivering-therapy-where-it-matters

User Image MadMaverick Posted - 1 day ago

$RNXT Breakthrough in pancreatic cancer treatment! 🚀 Interim study results show RenovoGem boosts survival by 6 months compared to standard chemo. Hope is on the horizon! MORE INFO BELOW 👇 https://chartingdaily.com/delivering-therapy-where-it-matters-now Communicated disclaimer $SLXN $TNXP

User Image MadMaverick Posted - 2 days ago

$RNXT - volume slowly flowing in, first day in five days. Technically it looks great over $1.20! 🎯- $1.40+ Also note, they have a trial readout in the 3 months that could change everything! More info about them 👇 https://chartingdaily.com/delivering-therapy-where-it-matters-now Communicated disclaimer $SOAR $NCNC $PRFX

User Image MadMaverick Posted - 3 days ago

This week, $RNXT looks to hold strong above $1.00 despite the market pullback. 🚀 Watching for any surge in buying volume to fuel a potential breakout. 👀 Clinical data delays suggest positive news with patients likely surviving. SB also giving off a bullish entry! 🎯 Upside targets for this week: $1.22, $1.31, $1.45. Need the full scoop on $RNXT? Check the link below! 👇 https://chartingdaily.com/delivering-therapy-where-it... Always manage risk! Communicated Disclaimer #stockmarket #Smallcaps $HCWB $ELAB $MRNA

User Image MadMaverick Posted - 1 week ago

$RNXT 📊 Nice volume shelf just below. As long as we hold $1$1.00, we could see some low volume into the company releases news or trial updates. Bullish signal is on the daily. RSI above 50, showing strength! https://chartingdaily.com/delivering-therapy-where-it-matters-now Communicated Disclaimer $MTEM $UAVS $AGFY $OMER

User Image MadMaverick Posted - 1 week ago

On $RNXT Upside to $1.80 is so clear - approaching massive breakout point over weekly EMA's. 🎤 Clinical data isn't coming back because their protocols are effective at keeping people alive. Do the math there 📑 $NMHI $MVST More about Stock Potential below 👇 https://chartingdaily.com/delivering-therapy-where-it-matters-now Communicated Disclaimer

User Image Northern_Lightz Posted - 1 week ago

Should You Invest in RenovoRX Now? $RNXT https://10xalerts.com/should-you-invest-in-renovorx-now/

User Image MadMaverick Posted - 1 week ago

Market is pulling back some today but $RNXT continues to hold above $1.00, that's positive. Looking for any signs of buying volume to present a bigger move to the upside! 👀 Clinical data delays = patients likely surviving = good 🎯Targets to upside are $1.22. $1.31, $1.45 If you miss the info about this company, check the link below 👇 https://chartingdaily.com/delivering-therapy-where-it-matters-now Always manage risk! Communicated disclaimer $BTCT $GNS $ADN $MNOV

User Image MadMaverick Posted - 1 week ago

$RNXT handling some business today , up 7% and 4% after hours! Will be one small cap stock I will stay watching into next week for more upside 👏👏 If you miss the info about this company , check the link below 👇 https://chartingdaily.com/delivering-therapy-where-it-matters-now Communicated disclaimer $NVOS $RIGL $TBIO $DJT

User Image pcguy2 Posted - 1 week ago

$RNXT Second interim analysis couldn't come sooner. If it stops the trial due to superiority, that's going to be WILD

User Image MadMaverick Posted - 2 weeks ago

$RNXT RenovoRx is revolutionizing cancer treatment with its groundbreaking TAMP™ technology, delivering chemotherapy directly to tumors for reduced side effects and enhanced efficacy. 🚀📈 With a projected 330% price surge, the company is turning heads in the investment world! 💼 RenovoGem™, their flagship product, is moving through crucial Phase III trials, positioning RenovoRx as a frontrunner in targeted cancer therapies. 💊🔬 Exciting times ahead for both investors and the future of oncology treatment! https://chartingdaily.com/delivering-therapy-where-it-matters-now Communicated Disclaimer - Do your own DD Waiting for the breakout! $MRNA $PFE $CELU $ATCH

User Image pcguy2 Posted - 2 weeks ago

$RNXT Any real humans here? Wish more people followed RNXT lol

User Image MadMaverick Posted - 1 month ago

$RNXT follow up.⚡⚡ We continue to hover around support and cannot seem to break out yet. That is where I will be interested to trade it up to the $1.30-$1.50 range. Keep these levels on WATCH! Some catalysts coming up this year: ⬇️ ◽Phase 3 TIGeR-PaC clinical trial: This is testing RenovoGem™ for locally advanced pancreatic cancer. Any significant positive updates, such as interim trial results or patient outcomes, could have a material impact on the stock. If the data shows improved efficacy, safety, or survival rates, this could serve as a major catalyst. ◽FDA Submissions: If RenovoRx submits a new drug application (NDA) for RenovoGem based on favorable trial data, it could drive interest in the stock. https://stockresearchtoday.com/delivering-therapy-where-it-matters/ Communicated Disclaimer $ZENA $TWG $VERB

User Image JB_Research Posted - 1 month ago

$RNXT CEO: "we expect this commercial 'stand-alone' RenovoCath strategy to accelerate our path to revenue generation, which we hope will occur during 2025..." https://ir.renovorx.com/news-events/press-releases/detail/101/renovorx-increases-production-of-fda-cleared-renovocath

User Image MadMaverick Posted - 1 month ago

$RNXT RenovoRx is revolutionizing cancer treatment with its groundbreaking TAMP™ technology, delivering chemotherapy directly to tumors for reduced side effects and enhanced efficacy. 🚀📈 With a projected 330% price surge, the company is turning heads in the investment world! 💼 RenovoGem™, their flagship product, is moving through crucial Phase III trials, positioning RenovoRx as a frontrunner in targeted cancer therapies. 💊🔬 Exciting times ahead for both investors and the future of oncology treatment! https://chartingdaily.com/delivering-therapy-where-it-matters Communicated Disclaimer - Do your own DD Waiting for the breakout! $ELAB $STEM $TOVX

User Image MadMaverick Posted - 1 month ago

$RNXT RenovoRx Price Target Raised to $8.25/Share From $8.00 by Ascendiant Capital So, a break of $1.18 - $1.20, sends it higher towards $1.40 next IMO More Info below https://chartingdaily.com/delivering-therapy-where-it-matters Communicated disclaimer - Do your own DD

User Image MadMaverick Posted - 09/30/24

Based on Morningstar, $RNXT has a fair value of $3.11. A 200% increase from current price. Only time will tell if we get there, any more positive news out of them could finally see a breakout of the wedge that’s been forming! So, a break of $1.18 - $1.20, sends it higher towards $1.40 next IMO https://chartingdaily.com/delivering-therapy-where-it-matters Communicated disclaimer $DUO $EMKR $RXRX

User Image MadMaverick Posted - 09/26/24

$RNXT - A hold of the $1 support is there with MFI turning more bullish over the last day or two. Recent news out today 👇 ◽Increases Production of FDA-Cleared RenovoCath Delivery System in Response to Strong Demand from Oncology and Interventional Radiology Physicians 📉Once we break out of this wedge, IT CAN GO! Click on our link for more details https://chartingdaily.com/delivering-therapy-where-it-matters Communicated Disclaimer - Do you own DD too. $TBIO $KTTA $BIIB $SBC

User Image pcguy2 Posted - 09/25/24

$RNXT THIS IS MASSIVE NEWS, and no reaction. Literally no one knows this company.

User Image enzomassimi Posted - 09/25/24

$RNXT

User Image OpenOutcrier Posted - 09/25/24

$RNXT (+12.7% pre) RenovoRx (RNXT) Increases Production of FDA-Cleared RenovoCath Delivery System in Response to Strong Demand from Oncology and Interventional Radiology Physicians - SI https://ooc.bz/l/43244

User Image hitmongreen Posted - 09/25/24

$RNXT 👀

User Image Stock_Titan Posted - 09/25/24

$RNXT RenovoRx Increases Production of FDA-Cleared RenovoCath® Delivery System in Response to Strong Demand from Oncology and Interventional Radiology Physicians https://www.stocktitan.net/news/RNXT/renovo-rx-increases-production-of-fda-cleared-renovo-cath-r-delivery-5sopou4xw1a6.html

User Image Northern_Lightz Posted - 09/24/24

With rising cancer rates, the need for targeted treatments is growing. $RNXT is a high-growth, early-stage opportunity in this expanding market 📈 and could be a game-changer in biotech. 🔬 Will you join the future of cancer treatment? #Investing #Biotech #Healthcare

Analyst Ratings
Ascendiant Capital Buy Sep 12, 24
Ascendiant Capital Buy Jun 17, 24
Alliance Global Partners Buy Feb 2, 24
Maxim Group Hold Nov 15, 23
Roth MKM Buy Aug 18, 23
Roth Capital Buy Nov 1, 21
Maxim Group Buy Oct 6, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Agah Ramtin Chief Medical Office.. Chief Medical Officer Jun 07 Buy 1.93 5,182 10,001 6,477 06/09/22
Bagai Shaun Chief Executive Offi.. Chief Executive Officer May 19 Buy 2.05 5,500 11,275 251,557 05/23/22